In a bid to challenge the Maharashtra FDA decision to cancel license to manufacture cosmetics from the Mulund facility, Johnson and Johnson has moved the Bombay HC, reports CNBC-TV18's Ashmit Kumar.
first published: Jul 19, 2013 07:21 pm
A collection of the most-viewed Moneycontrol videos.

Nifty Slips Below 26,100 Amid Sluggish Trade, Midcaps Struggle; IT Lends Support | Closing Bell Live

Live: Can Nifty reach its all-time high levels this week? | Opening Bell

This Tenant says Andheri West is better than SOBO | The tenant

Nifty Clocks Second Week Of Gains But Still Awaits New Peak;Midcaps Snap 7-Week Run|Closing Bell
You are already a Moneycontrol Pro user.

